Monitoring treatment effects in lung cancer-bearing mice: clinical CT and clinical MRI compared to micro-CT

Abstract

Background Compared to histology-based methods, imaging can reduce animal usage in preclinical studies. However, availability of dedicated scanners is limited. We evaluated clinical computed tomography (CT) and magnetic resonance imaging (MRI) in comparison to dedicated CT (micro-CT) for assessing therapy effects in lung cancer-bearing mice. Methods Animals received cisplatin (n = 10), sham (n = 12), or no treatment (n = 9). All were examined via micro-CT, CT, and MRI before and after treatment. Semiautomated tumour burden (TB) calculation was performed. The Bland-Altman, receiver operating characteristic (ROC), and Spearman statistics were used. Results All modalities always allowed localising and measuring TB. At all modalities, mice treated with cisplatin showed a TB reduction (p ≤ 0.012) while sham-treated and untreated individuals presented tumour growth (p < 0.001). Mean relative difference (limits of agreement) between TB on micro-CT and clinical scanners was 24.7% (21.7–27.7%) for CT and 2.9% (−4.0–9.8%) for MRI. Relative TB changes before/after treatment were not different between micro-CT and CT (p = 0.074) or MRI (p = 0.241). Mice with cisplatin treatment were discriminated from those with sham or no treatment at all modalities (p ≤ 0.001). Using micro-CT as reference standard, ROC areas under the curves were 0.988–1.000 for CT and 0.946–0.957 for MRI. TB changes were highly correlated across modalities (r ≥ 0.900, p < 0.001). Conclusions Clinical CT and MRI are suitable for treatment response evaluation in lung cancer-bearing mice. When dedicated scanners are unavailable, they should be preferred to improve animal welfare.

Deep Learning-Based Chest CT Image Features in Diagnosis of Lung Cancer

“…These methods have both advantages and limitations. For example, the radiation dose of CXR and CT is low, but MRI and PET have certain limitations in detecting and diagnosing lung nodules [ 21 , 22 ]. As an important feature of early lung cancer, rapid and effective diagnosis of lung nodules can effectively improve the survival rate of patients with lung diseases.…”

Inhibition of Ehrlich ascites carcinoma growth by melatonin: Studies with micro-CT

“…Resolution at the cellular level is likely to increase soon, as the existing theoretical limits of X-ray imaging are greater than those of optical imaging and as micro-CT imaging technology is advancing day by day. In their study, Spiro et al compared micro-CT with clinical CT and clinical MRI regarding the monitoring of treatment effects in mice with lung cancer and found that micro-CT could be an appropriate method for evaluating the response to treatment in mice with cancer [42].…”

Glycolytic Plasticity of Metastatic Lung Cancer Captured by Noninvasive 18F-FDG PET/CT and Serum 1H-NMR Analysis: An Orthotopic Murine Model Study

“…Furthermore, fused PET/CT images, metastases in the lung and thorax, even in the abdomen and liver, could be detected more precisely and accurately by PET/CT [ 32 ]. Although chest computed tomography (CT) is the most effective imaging tool for diagnosing primary lung cancer in clinical practice and preclinical studies [ 33 ], technical constraints still exist in detecting small metastases. These exemplified the complementary roles of PET and metabolomics approaches in this platform.…”